Search Results
| No. |
VISDB ID▲▼ |
Virus Name▲▼ |
Subtype▲▼ |
Virus Genome▲▼ |
Breakpoint 1▲▼ |
Breakpoint 2▲▼ |
Human Genome▲▼ |
Chr▲▼ |
Start▲▼ |
End▲▼ |
Loci▲▼ |
Target Gene▲▼ |
Sample Type▲▼ |
Disease▲▼ |
Method▲▼ |
PubMed ID▲▼ |
Year▲▼ |
Curated Way▲▼ |
| 8201 |
TVIS20025063
|
Human Papillomavirus |
HPV16 |
K02718 |
1046 |
- |
hg38 |
chr20 |
3921435 |
3921435 |
p13 |
ENSG00000275582, PANK2 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8202 |
TVIS20025064
|
Human Papillomavirus |
HPV16 |
K02718 |
1723 |
- |
hg38 |
chr17 |
31654547 |
31654547 |
q11.2 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8203 |
TVIS20025065
|
Human Papillomavirus |
HPV16 |
K02718 |
1000 |
- |
hg38 |
chr20 |
55843708 |
55843708 |
q13.2 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8204 |
TVIS20025066
|
Human Papillomavirus |
HPV16 |
K02718 |
6936 |
- |
hg38 |
chr8 |
73522758 |
73522758 |
q21.11 |
STAU2 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8205 |
TVIS20025067
|
Human Papillomavirus |
HPV16 |
K02718 |
7114 |
- |
hg38 |
chr2 |
219628976 |
219628976 |
q35 |
SLC4A3 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8206 |
TVIS20025068
|
Human Papillomavirus |
HPV16 |
K02718 |
1390 |
- |
hg38 |
chrX |
87318949 |
87318949 |
q21.31 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8207 |
TVIS20025069
|
Human Papillomavirus |
HPV16 |
K02718 |
740 |
- |
hg38 |
chr20 |
56882791 |
56882791 |
q13.31 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8208 |
TVIS20025070
|
Human Papillomavirus |
HPV16 |
K02718 |
3553 |
- |
hg38 |
chr3 |
41577641 |
41577641 |
p22.1 |
ULK4 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8209 |
TVIS20025071
|
Human Papillomavirus |
HPV16 |
K02718 |
2147 |
- |
hg38 |
chr1 |
27324017 |
27324017 |
p36.11 |
TMEM222 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8210 |
TVIS20025072
|
Human Papillomavirus |
HPV16 |
K02718 |
1313 |
- |
hg38 |
chr5 |
84429509 |
84429509 |
q14.3 |
EDIL3-DT |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |